title: CPAP decreases lung hyperinflation in patients with stable COPD.
abstract: BACKGROUND
  Dynamic hyperinflation, caused by expiratory flow limitation, markedly increases resting end-expiratory lung volume (functional residual capacity) in many COPD patients.
  
  
  OBJECTIVE
  To determine the impact and duration of impact of CPAP on hyperinflation and airway resistance in patients with stable COPD.
  
  
  METHODS
  In a case series, 21 patients underwent CPAP at 8 cm H(2)O for 15 min, then whole-body plethysmography immediately after, and at 15 and 30 min after CPAP.
  
  
  RESULTS
  The cohort's mean ± SD age was 70 ± 9 y, and the mean FEV(1) was 41 ± 8% of predicted. Residual volume, functional residual capacity, total lung capacity, the ratio of residual volume to total lung capacity, and airway resistance decreased after CPAP and did not significantly change at 15 min (P < .001), but returned to baseline at 30 min.
  
  
  CONCLUSIONS
  In patients with severe to very severe stable COPD, CPAP reduces lung volumes and airway resistance for 15 min, but the lung volumes return to baseline by 30 min.
authors.affiliation: Rehabilitation Science Graduate Program, Augusto Motta University, Rio de Janeiro, Brazil.
authors.forename: Agnaldo J
authors.initials: AJ
authors.lastname: Lopes
authors.forename: Flávio Pos
authors.initials: FP
authors.lastname: Nery
authors.forename: Felipe C
authors.initials: FC
authors.lastname: Sousa
authors.forename: Fernando S
authors.initials: FS
authors.lastname: Guimarães
authors.forename: Cristina M
authors.initials: CM
authors.lastname: Dias
authors.forename: Juliana F
authors.initials: JF
authors.lastname: Oliveira
authors.forename: Sara Ls
authors.initials: SL
authors.lastname: Menezes
mesh_terms: D000368:Aged; D000403:Airway Resistance; D045422:Continuous Positive Airway Pressure / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008176:Lung Volume Measurements; D008297:Male; D011446:Prospective Studies; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D011656:Pulmonary Emphysema / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D015656:Respiratory Mechanics; D014109:Total Lung Capacity / Q000502:physiology*; D016896:Treatment Outcome